Nanotechnology-Empowered Antigen Assay Methods for the Control of Infectious Diseases

Strategic Insights -

Scientists at Shanghai University, in collaboration with international researchers, have made significant progress in developing immunological assay methods for infectious diseases. Using nanotechnology, they have engineered biosensing interfaces that enhance sensitivity while maintaining convenience for on-site diagnosis. The research highlights the potential of this approach in controlling the spread of infectious diseases, such as COVID-19 caused by the new coronavirus (SARS-CoV-2). The study, published in The Analyst, underscores the importance of rapid and accurate detection of pathogens to prevent severe illness and death.

Key Takeaways:

  • The global spread of air-borne diseases, such as COVID-19, has significantly impacted public health and economic development worldwide.
  • Rapid antigen testing for pathogen proteins shows unique advantages, including convenience, speed, and cost-effectiveness, but its sensitivity is limited.
  • Immunological assay methods for infectious diseases have been developed, utilizing nanotechnology to engineer biosensing interfaces with enhanced sensitivity.
  • The researchers review the principles, performance, advantages, and limitations of several representative immunological assay methods.
  • Recent efforts in utilizing nanotechnology have improved biosensing interfaces, offering enhanced sensitivity while maintaining convenience for on-site diagnosis.
  • The study highlights the development of a field that offers enhanced sensitivity while maintaining convenience for on-site diagnosis.

Statistics:

  • The global spread of air-borne diseases has significantly impacted public health and economic development worldwide.
  • Rapid antigen testing for pathogen proteins has shown unique advantages, including convenience, speed, and cost-effectiveness, but its sensitivity is limited.
  • The use of nanotechnology has improved biosensing interfaces, offering enhanced sensitivity while maintaining convenience for on-site diagnosis.
  • The researchers review the principles, performance, advantages, and limitations of several representative immunological assay methods.

Sources:

  • NewsRx. Shanghai University Reports Findings in Coronavirus (Recent development of nanotechnology-empowered antigen assay methods for the control of infectious diseases). Nanotechnology Weekly. June 19, 2023; p 1575.
  • Recent development of nanotechnology-empowered antigen assay methods for the control of infectious diseases. The Analyst, 2023.
  • The Analyst can be contacted at: Royal Soc Chemistry, Thomas Graham House, Science Park, Milton Rd, Cambridge CB4 0WF, Cambs, England.